Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Leukemia, Biphenotypic, Acute 6Leukemia, Myeloid, Acute 5Carcinoma, Non-Small-Cell Lung 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Lung Neoplasms 4Burkitt Lymphoma 4Wilms Tumor 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3Pancreatic Neoplasms 3Osteosarcoma 3Neuroblastoma 3Ganglioneuroblastoma 3Teratoma 2Sarcoma, Ewing 2Rhabdomyosarcoma 2Prostatic Neoplasms 2Melanoma 2Medulloblastoma 2Lymphoma, Non-Hodgkin 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma 2Hepatoblastoma 2Hematologic Neoplasms 2Fibrolamellar hepatocellular carcinoma 2Desmoid Tumors 2Carcinoma, Embryonal 2Anatomic Stage I Breast Cancer AJCC v8 2Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1

Interventions

lorvotuzumab mertansine 1Watchful Waiting 1Vincristine 1Topotecan 1Specimen Handling 1Razoxane 1Polymerase Chain Reaction 1Observation 1Magnetic Resonance Spectroscopy 1Ifosfamide 1High-Energy Shock Waves 1Gene Rearrangement 1Gene Expression Profiling 1Doxorubicin 1Dexrazoxane 1Dactinomycin 1Cytogenetic Analysis 1Cyclophosphamide 1Amplified Fragment Length Polymorphism Analysis 1Ado-Trastuzumab Emtansine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Pleuropulmonary blastoma × Specimen Handling × Clear all
NCT06647953 2026-05-05

Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma

Children's Oncology Group

Phase 3 Recruiting
110 enrolled

Pleuropulmonary blastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡